Israel Bio-pharma Research Market - Forecast to 2020

Israel Bio-pharma Research Market - Forecast to 2020

Regular price $2,650.00 Sale

Published on Oct 01, 2015 - 133 pages

Israel Bio-pharma Research Market [Product (Consumables-Assay, Kits and Reagent, Cell Line, Instrument {Separation, Imaging}, Software, Services)], [End User (Biotechnology/Biopharmaceutical Company/ CROs, Academic and Research institute)]- Forecast to 2020

The purpose of this report is to cover the definition, description, and forecast of the Israel bio-pharma research market. It involves a deep dive analysis of the market segmentation, which is based on products & services and end-user. The report also gives deep insights into the competitive landscape of the market through a strategic analysis of the key players of the market. On the basis of products and services, the Israel bio-pharma research market is segmented into instruments, consumables, bioreactors, services, and software. The consumables market is expected to account for largest share of the Israel bio-pharma research market in 2015. This largest share is attributed to the increasing usage of consumables along with automation and advancements in detection technologies. However, the software market is expected to witness the highest growth during the forecast period, owing to the advancements in bioinformatics tools.

Israel bio-pharma research market is subsegmented into biotechnology/biopharmaceutical companies/CROs and academic and research institutes on basis of end users. The biotechnology/biopharmaceutical companies/CROs segment is expected to account for largest share of the Israel bio-pharma research market in 2015. This largest share is attributed to factors such as the technological advancements, increased investments from governments and private companies.

The report also provides a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, news & deals, M&As, and segment-specific pipeline products, product approvals of the major companies have been detailed in the report. The main companies operating in this market are Thermo Fisher Scientific Inc. (U.S.), Merck KGAA (Germany), Perkinelmer Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Becton, Dickinson and Company (U.S.).



Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 KEY DATA FROM PRIMARY SOURCES
2.2.2.1 KEY INDUSTRY INSIGHTS
2.2.3 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ISRAEL BIO-PHARMA RESEARCH MARKET TO GROW AT A STEADY RATE
4.2 ISRAEL BIO-PHARMA RESEARCH MARKET, BY PRODUCTS AND SERVICES
4.3 ISRAEL BIO-PHARMA RESEARCH MARKET, BY INSTRUMENTS AND CONSUMABLES
4.4 ISRAEL BIO-PHARMA RESEARCH MARKET, BY INSTRUMENT
4.5 ISRAEL BIO-PHARMA RESEARCH MARKET, BY END USER
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET EVOLUTION
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 RISING NUMBER OF PHARMACEUTICAL AND BIOTECH START-UPS
5.3.1.2 GOVERNMENT SUPPORT TO BOOST R&D ACTIVITIES
5.3.1.3 SUFFICIENT INVESTMENTS AND VENTURE CAPITAL FUNDS
5.3.1.4 AVAILABILITY OF SKILLED AND DIVERSE WORKFORCE
5.3.2 RESTRAINTS
5.3.3 OPPORTUNITIES
5.3.3.1 MERGERS & ACQUISITIONS
5.3.4 CURRENT TRENDS
5.3.4.1 ISRAELI BIOPHARMACEUTICAL COMPANIES INITIATING IPOS
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 MAJOR PRE-CLINICAL TRIALS OF BIOPHARMACEUTICAL PRODUCTS IN ISRAEL
6.3 ONGOING BIOPHARMACEUTICAL CLINICAL TRIALS IN ISRAEL
6.4 BUDGET/ PLANNED INVESTMENTS
7 ISRAEL HEALTHCARE SYSTEM
7.1 OVERVIEW
7.2 HISTORICAL DEVELOPMENT OF THE HEALTH SYSTEM IN ISRAEL
7.3 HEALTHCARE INDUSTRY IN ISRAEL
7.4 DISEASE BURDEN IN ISRAEL
7.5 HEALTHCARE EXPENDITURE IN ISRAEL
7.6 DRUG FUNDING/REIMBURSEMENT APPROVAL PROCESS
7.7 LEGAL REGULATORY FRAMEWORK OF CLINICAL TRIALS IN ISRAEL
7.7.1 LEGISLATION
7.7.2 REGULATORY AUTHORIZATION
7.7.3 DOCUMENTS REQUIRED
7.7.4 CLINICAL TRIAL APPROVAL PROCESS AND TIMELINE
7.8 ISRAEL: PHARMACEUTICAL IMPORT AND EXPORT
8 ISRAEL BIO-PHARMA RESEARCH MARKET, BY PRODUCTS AND SERVICES
8.1 INTRODUCTION
8.2 CONSUMABLES
8.2.1 INTRODUCTION
8.2.2 ASSAYS KITS AND REAGENTS
8.2.3 CELL CULTURE MEDIA
8.2.4 CELL LINES
8.2.5 MICROPLATES
8.2.6 OTHER CONSUMABLES
8.3 INSTRUMENTS
8.3.1 SEPARATION INSTRUMENTS
8.3.2 DETECTION AND SCREENING EQUIPMENT
8.3.3 IMAGING INSTRUMENTS
8.3.4 AUTOMATION AND HIGH-THROUGHPUT SCREENING INSTRUMENTS
8.3.5 OTHER INSTRUMENTS
 
8.4 BIOREACTORS
8.4.1 STAINLESS STEEL BIOREACTORS
8.4.2 SINGLE-USE BIOREACTORS
8.5 SOFTWARE
8.6 SERVICES
9 ISRAEL BIO-PHARMA RESEARCH MARKET, BY END USER
9.1 INTRODUCTION
9.2 BIOTECHNOLOGY/BIOPHARMACEUTICAL COMPANIES/CROS
9.3 ACADEMIC AND RESEARCH INSTITUTES
10 COMPANY PROFILES
(Overview, Financials, Products & Services, Strategy, and Developments)*
10.1 AGILENT TECHNOLOGIES
10.2 BIO-RAD LABORATORIES, INC.
10.3 THERMO FISHER SCIENTIFIC, INC.
10.4 MERCK KGAA
10.5 PERKINELMER, INC.
10.6 SIGMA-ALDRICH CORPORATION
10.7 WATERS CORPORATION
10.8 SARTORIUS AG
10.9 BECTON, DICKINSON AND COMPANY
10.10 GENE BIO-APPLICATION LTD.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
11 MARKET SHARE ANALYSIS

LIST OF TABLES

TABLE 1 RISING NUMBER OF PHARMACEUTICAL & BIOTECH START-UPS AND GOVERNMENT SUPPORT TO DRIVE THE ISRAEL BIO-PHARMA RESEARCH MARKET
TABLE 2 STRINGENT REGULATIONS FOR DRUG PRICING TO RESTRAIN THE ISRAEL BIO-PHARMA RESEARCH MARKET GROWTH
TABLE 3 MERGERS AND ACQUISITIONS ARE PROVIDING SIGNIFICANT GROWTH OPPORTUNITIES FOR THE ISRAEL BIO-PHARMA RESEARCH MARKET
TABLE 4 ISRAEL: HEALTHCARE INDUSTRY, BY SECTOR, 2014
TABLE 5 ISRAEL: TOP DISEASES WITH HIGH MORTALITY RATES, 2012
TABLE 6 ISRAEL: NATIONAL EXPENDITURE ON HEALTH, BY TYPE OF SERVICE, OPERATING SECTOR, AND TYPE OF EXPENDITURE, 2012
TABLE 7 SUBMISSION PACKAGE REQUIRED FOR APPROVAL OF A CLINICAL STUDY IN ISRAEL
TABLE 8 ISRAEL: TOP IMPORTS, 2014
TABLE 9 ISRAEL: TOP EXPORTS, 2014
TABLE 10 LIST OF 17 MAJOR COMPANIES IN ISRAEL EXPORTING MEDICINE TO THE U.S., 2012
TABLE 11 ISRAEL BIO-PHARMA RESEARCH MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD MILLION)
TABLE 12 ISRAEL BIO-PHARMA RESEARCH CONSUMABLES MARKET SIZE, BY TYPE, 2013--2020 (USD MILLION)